Cipla launches CipAir®: AI-Powered App Revolutionizing Asthma Screening in India Kumar Jeetendra | December 18, 2024 Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the launch of CipAir®️, a mobile application designed to enable timely and convenient first line of screening for asthma in India. This first-of-its-kind technology is clinically validated through a multi-centric pan-India study. It aims to empower people by helping them understand their …
Pharma Horizons 2025 Kumar Jeetendra | February 7, 2025 The year 2025 is approaching, and the pharmaceutical sector is at a crossroads of change, facing clashing innovations from science, technology, and policy implementations. All of these changes are going to alter the landscape of drug development. So, which driving factors dictate this development and how will they impact medicine in the future? Let’s take …
